China Universal Asset Management Co., Ltd. reduced its holdings in Keymed Biosciences-B (02162.HK) by 991,000 shares at approximately HK$70.9 per share.

Zhitong Finance APP has learned that the latest data from the Hong Kong Stock Exchange shows that on October 27, China Universal Asset Management Co., Ltd. reduced its holdings of Keymed Biosciences-B (02162.HK) by 991,000 shares at HK$70.8951 per share, for a total amount of approximately HK$70.2570 million. After the reduction, its latest shareholding was 14,197,500 shares, representing a 4.75% stake.